.
United Nations Inter-Agency Task Force on NCDs (UNIATF)
The Secretariat of the WHO FCTC and UNIATF
Since 2013, the Convention Secretariat has been an independent member of UNIATF and ensures that implementation of the WHO FCTC remains a key focus.
Videos
.tmb-549v.jpg?Culture=en&sfvrsn=70d9bea6_16)
Latest events
News
Resources
FCTC/COP/11/15 Review of accreditation of nongovernmental organizations with the status of observer to the Conference of the Parties
FCTC/COP/11/14 Payment of Assessed Contributions and measures to reduce Parties in arrears
FCTC/COP/11/13 Proposed Workplan and Budget for the financial period 2026–2027
FCTC/COP/11/10 Implementation of measures to prevent and reduce tobacco consumption, nicotine addiction and exposure to tobacco smoke, and the protection of such measures from commercial and other vested interests of the tobacco industry in light
Geneva, Switzerland
FCTC/COP/11/9 Regulation of contents and disclosure of tobacco products (Articles 9 and 10 of the WHO FCTC)
Geneva, Switzerland
FCTC/COP/11/8 Regulation of contents and disclosure of tobacco products (Articles 9 and 10 of the WHO FCTC)
Geneva, Switzerland
FCTC/COP/11/7 Protection of the environment and the health of persons (Article 18 of the WHO FCTC)
Geneva, Switzerland
FCTC/COP/11/6 Liability (Article 19 of the WHO FCTC)
Geneva, Switzerland
FCTC/COP/11/5 Forward-looking tobacco control measures (in relation to Article 2.1 of the WHO FCTC)
Geneva, Switzerland
FCTC/COP/11/4 Global progress in implementation of the WHO FCTC
Geneva, Switzerland
FCTC/COP/11/3 Applications for the status of observer to the Conference of the Parties
Geneva, Switzerland
FCTC/COP/11/2 Credentials of participants
Geneva, Switzerland
FCTC/COP/11/1 Provisional agenda annotated
Geneva, Switzerland
WHO Centre for Health Development, Kobe, Japan: 30th anniversary report, 1995–2025
FCTC/COP/11/17 Date and place of the Twelfth session of the Conference of the Parties
Recommendations on the role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria
Over the past decade, mass drug administration (MDA) and other approaches to mass screening and treatment have received increasing interest in the context of malaria elimination and, more recently, in emergency situations such as the Ebola epidemic in West Africa.
Based on recent evidence, the WHO Malaria Policy Advisory Committee (MPAC) made specific recommendations on the role of MDA, mass screening and treatment (MSAT) and focal screening and treatment for malaria (FSAT).
Related document
Related links
WHO guidance on malaria
FCTC/MOP/4/16 Election of the President and Vice-Presidentsof the Meeting of the Parties
FCTC/MOP/4/1 Provisional agenda
Geneva, Switzerland
24-26 November 2025